<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>PILMAN &#187; Heparin</title>
	<atom:link href="http://www.tapanray.in/tag/heparin/feed/" rel="self" type="application/rss+xml" />
	<link>http://www.tapanray.in</link>
	<description>A Tapan Ray Website</description>
	<lastBuildDate>Sun, 22 Mar 2026 10:59:18 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.org/?v=3.4.2</generator>
		<item>
		<title>FDA &#8216;Import Bans&#8217;: Valuing Drug Supply Chain Security for Patients&#8217; Safety</title>
		<link>http://www.tapanray.in/fda-import-bans-valuing-drug-supply-chain-security-for-patients-safety/?utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=fda-import-bans-valuing-drug-supply-chain-security-for-patients-safety</link>
		<comments>http://www.tapanray.in/fda-import-bans-valuing-drug-supply-chain-security-for-patients-safety/#comments</comments>
		<pubDate>Mon, 03 Feb 2014 00:00:19 +0000</pubDate>
		<dc:creator>Tapan Ray</dc:creator>
				<category><![CDATA[Pharma]]></category>
		<category><![CDATA[bans]]></category>
		<category><![CDATA[chain]]></category>
		<category><![CDATA[Drug]]></category>
		<category><![CDATA[DSCS]]></category>
		<category><![CDATA[Heparin]]></category>
		<category><![CDATA[import]]></category>
		<category><![CDATA[India]]></category>
		<category><![CDATA[pharmaceutical]]></category>
		<category><![CDATA[pivotal]]></category>
		<category><![CDATA[Ray]]></category>
		<category><![CDATA[reinforce]]></category>
		<category><![CDATA[Security]]></category>
		<category><![CDATA[Supply]]></category>
		<category><![CDATA[Tapan]]></category>
		<category><![CDATA[Tylenol]]></category>
		<category><![CDATA[UKMHRA]]></category>
		<category><![CDATA[USFDA]]></category>

		<guid isPermaLink="false">http://www.tapanray.in/?p=4926</guid>
		<description><![CDATA[To strengthen patients’ health and safety requirements, there is a growing need to first work out and then maintain a robust Drug Supply Chain Security (DSCS) mechanism by the pharmaceutical product manufacturers located anywhere in the world. It is, therefore, &#8230; <a href="http://www.tapanray.in/fda-import-bans-valuing-drug-supply-chain-security-for-patients-safety/">Continue reading <span class="meta-nav">&#8594;</span></a>]]></description>
		<wfw:commentRss>http://www.tapanray.in/fda-import-bans-valuing-drug-supply-chain-security-for-patients-safety/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Is Fraud or Negligence in Drug Quality Standards Not a Fraud on Patients?</title>
		<link>http://www.tapanray.in/is-fraud-or-negligence-in-drug-quality-standards-not-a-fraud-on-patients/?utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=is-fraud-or-negligence-in-drug-quality-standards-not-a-fraud-on-patients</link>
		<comments>http://www.tapanray.in/is-fraud-or-negligence-in-drug-quality-standards-not-a-fraud-on-patients/#comments</comments>
		<pubDate>Mon, 03 Jun 2013 00:00:06 +0000</pubDate>
		<dc:creator>Tapan Ray</dc:creator>
				<category><![CDATA[Pharma]]></category>
		<category><![CDATA[abbott]]></category>
		<category><![CDATA[Americans]]></category>
		<category><![CDATA[anywhere]]></category>
		<category><![CDATA[Baxter]]></category>
		<category><![CDATA[Boehringer]]></category>
		<category><![CDATA[branded]]></category>
		<category><![CDATA[breach]]></category>
		<category><![CDATA[cadila]]></category>
		<category><![CDATA[chain]]></category>
		<category><![CDATA[charitable]]></category>
		<category><![CDATA[China]]></category>
		<category><![CDATA[Claris]]></category>
		<category><![CDATA[contamination]]></category>
		<category><![CDATA[DCGI]]></category>
		<category><![CDATA[Dewas]]></category>
		<category><![CDATA[Dr. Reddy's]]></category>
		<category><![CDATA[DRL]]></category>
		<category><![CDATA[Drug]]></category>
		<category><![CDATA[everywhere]]></category>
		<category><![CDATA[facilities]]></category>
		<category><![CDATA[fraud]]></category>
		<category><![CDATA[generic]]></category>
		<category><![CDATA[GlaxoSmithKline]]></category>
		<category><![CDATA[GSK]]></category>
		<category><![CDATA[Heparin]]></category>
		<category><![CDATA[Hospira]]></category>
		<category><![CDATA[Hospital]]></category>
		<category><![CDATA[IMA]]></category>
		<category><![CDATA[India]]></category>
		<category><![CDATA[Indian]]></category>
		<category><![CDATA[Ingelheim]]></category>
		<category><![CDATA[ingredients]]></category>
		<category><![CDATA[Integrity]]></category>
		<category><![CDATA[Jaslok]]></category>
		<category><![CDATA[Jubilant]]></category>
		<category><![CDATA[Lupin]]></category>
		<category><![CDATA[manufacturing]]></category>
		<category><![CDATA[Medical Association]]></category>
		<category><![CDATA[Mumbai]]></category>
		<category><![CDATA[OSCS]]></category>
		<category><![CDATA[paonta]]></category>
		<category><![CDATA[pew]]></category>
		<category><![CDATA[Pharmaceuticals]]></category>
		<category><![CDATA[plants]]></category>
		<category><![CDATA[prescription]]></category>
		<category><![CDATA[Project]]></category>
		<category><![CDATA[Quality]]></category>
		<category><![CDATA[Ranbaxy]]></category>
		<category><![CDATA[Ray]]></category>
		<category><![CDATA[sahib]]></category>
		<category><![CDATA[Schering-Plough]]></category>
		<category><![CDATA[SCS]]></category>
		<category><![CDATA[Security]]></category>
		<category><![CDATA[Show]]></category>
		<category><![CDATA[stakeholder]]></category>
		<category><![CDATA[standards]]></category>
		<category><![CDATA[Supply]]></category>
		<category><![CDATA[Tapan]]></category>
		<category><![CDATA[tolerance]]></category>
		<category><![CDATA[tragedy]]></category>
		<category><![CDATA[trusts]]></category>
		<category><![CDATA[USFDA]]></category>
		<category><![CDATA[wockhardt]]></category>
		<category><![CDATA[Wyeth]]></category>
		<category><![CDATA[zero]]></category>
		<category><![CDATA[Zydus]]></category>

		<guid isPermaLink="false">http://www.tapanray.in/?p=2607</guid>
		<description><![CDATA[As we know, a substance is called a drug when it has scientifically proven and well documented efficacy and safety profile to reduce both mortality and morbidity of patients. Any fraud or negligence in the drug quality standards, for whatever &#8230; <a href="http://www.tapanray.in/is-fraud-or-negligence-in-drug-quality-standards-not-a-fraud-on-patients/">Continue reading <span class="meta-nav">&#8594;</span></a>]]></description>
		<wfw:commentRss>http://www.tapanray.in/is-fraud-or-negligence-in-drug-quality-standards-not-a-fraud-on-patients/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>The importance of ‘Supply Chain Integrity’ in ‘Global Supply Chain Management (GSCM)’ process</title>
		<link>http://www.tapanray.in/the-importance-of-supply-chain-integrity-in-global-supply-chain-management-gscm-process/?utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=the-importance-of-supply-chain-integrity-in-global-supply-chain-management-gscm-process</link>
		<comments>http://www.tapanray.in/the-importance-of-supply-chain-integrity-in-global-supply-chain-management-gscm-process/#comments</comments>
		<pubDate>Mon, 29 Nov 2010 01:00:07 +0000</pubDate>
		<dc:creator>Tapan Ray</dc:creator>
				<category><![CDATA[Pharma]]></category>
		<category><![CDATA[chain]]></category>
		<category><![CDATA[global]]></category>
		<category><![CDATA[Government]]></category>
		<category><![CDATA[GSCM]]></category>
		<category><![CDATA[Heparin]]></category>
		<category><![CDATA[importance]]></category>
		<category><![CDATA[in]]></category>
		<category><![CDATA[India]]></category>
		<category><![CDATA[Integrity]]></category>
		<category><![CDATA[management]]></category>
		<category><![CDATA[of]]></category>
		<category><![CDATA[Pharmaceuticals]]></category>
		<category><![CDATA[process]]></category>
		<category><![CDATA[Ray]]></category>
		<category><![CDATA[SCS]]></category>
		<category><![CDATA[Supply]]></category>
		<category><![CDATA[Tapan]]></category>
		<category><![CDATA[tragedy]]></category>

		<guid isPermaLink="false">http://tapanray.in/index.php/?p=342</guid>
		<description><![CDATA[Since the last decade with increasing pace of change, mostly in the western world has accelerated the globalization process in the Pharmaceutical Industry across the world. The key drivers to these changes are as follows: 1. A large number of &#8230; <a href="http://www.tapanray.in/the-importance-of-supply-chain-integrity-in-global-supply-chain-management-gscm-process/">Continue reading <span class="meta-nav">&#8594;</span></a>]]></description>
		<wfw:commentRss>http://www.tapanray.in/the-importance-of-supply-chain-integrity-in-global-supply-chain-management-gscm-process/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Create, Deliver and Realize maximum value from a new product launch with an innovative Supply Chain Management system</title>
		<link>http://www.tapanray.in/create-deliver-and-realize-maximum-value-from-a-new-product-launch-with-an-innovative-supply-chain-management-system/?utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=create-deliver-and-realize-maximum-value-from-a-new-product-launch-with-an-innovative-supply-chain-management-system</link>
		<comments>http://www.tapanray.in/create-deliver-and-realize-maximum-value-from-a-new-product-launch-with-an-innovative-supply-chain-management-system/#comments</comments>
		<pubDate>Mon, 30 Aug 2010 01:00:49 +0000</pubDate>
		<dc:creator>Tapan Ray</dc:creator>
				<category><![CDATA[Pharma]]></category>
		<category><![CDATA[a]]></category>
		<category><![CDATA[an]]></category>
		<category><![CDATA[and]]></category>
		<category><![CDATA[chain]]></category>
		<category><![CDATA[create]]></category>
		<category><![CDATA[deliver]]></category>
		<category><![CDATA[From]]></category>
		<category><![CDATA[Heparin]]></category>
		<category><![CDATA[innovative]]></category>
		<category><![CDATA[launch]]></category>
		<category><![CDATA[logistics]]></category>
		<category><![CDATA[management]]></category>
		<category><![CDATA[manufacturing]]></category>
		<category><![CDATA[marketing]]></category>
		<category><![CDATA[maximum]]></category>
		<category><![CDATA[New]]></category>
		<category><![CDATA[Product]]></category>
		<category><![CDATA[Ray]]></category>
		<category><![CDATA[Realize]]></category>
		<category><![CDATA[SCS]]></category>
		<category><![CDATA[Supply]]></category>
		<category><![CDATA[system]]></category>
		<category><![CDATA[Tapan]]></category>
		<category><![CDATA[value]]></category>
		<category><![CDATA[with]]></category>

		<guid isPermaLink="false">http://tapanray.in/index.php/?p=381</guid>
		<description><![CDATA[Like in many other industries, effective supply-chain management (SCM) in the pharmaceutical industry involves a systematic process, spanning from procurement of raw, packaging and other related materials, converting those materials into finished goods stock keeping units (SKUs), inventory management of &#8230; <a href="http://www.tapanray.in/create-deliver-and-realize-maximum-value-from-a-new-product-launch-with-an-innovative-supply-chain-management-system/">Continue reading <span class="meta-nav">&#8594;</span></a>]]></description>
		<wfw:commentRss>http://www.tapanray.in/create-deliver-and-realize-maximum-value-from-a-new-product-launch-with-an-innovative-supply-chain-management-system/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>To avoid “Heparin” like tragedy in future, a robust “supply chain integrity and security” system is of critical importance</title>
		<link>http://www.tapanray.in/to-avoid-heparin-like-tragedy-in-future-a-robust-supply-chain-integrity-and-security-system-is-of-critical-importance/?utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=to-avoid-heparin-like-tragedy-in-future-a-robust-supply-chain-integrity-and-security-system-is-of-critical-importance</link>
		<comments>http://www.tapanray.in/to-avoid-heparin-like-tragedy-in-future-a-robust-supply-chain-integrity-and-security-system-is-of-critical-importance/#comments</comments>
		<pubDate>Mon, 29 Mar 2010 00:30:14 +0000</pubDate>
		<dc:creator>Tapan Ray</dc:creator>
				<category><![CDATA[Pharma]]></category>
		<category><![CDATA[a]]></category>
		<category><![CDATA[and]]></category>
		<category><![CDATA[avoid]]></category>
		<category><![CDATA[chain]]></category>
		<category><![CDATA[critical]]></category>
		<category><![CDATA[future]]></category>
		<category><![CDATA[Heparin]]></category>
		<category><![CDATA[importance]]></category>
		<category><![CDATA[in]]></category>
		<category><![CDATA[Integrity]]></category>
		<category><![CDATA[is]]></category>
		<category><![CDATA[like]]></category>
		<category><![CDATA[of]]></category>
		<category><![CDATA[pharmaceutical]]></category>
		<category><![CDATA[Ray]]></category>
		<category><![CDATA[Robust]]></category>
		<category><![CDATA[SCM]]></category>
		<category><![CDATA[SCS]]></category>
		<category><![CDATA[Security]]></category>
		<category><![CDATA[Supply]]></category>
		<category><![CDATA[system]]></category>
		<category><![CDATA[Tapan]]></category>
		<category><![CDATA[to]]></category>
		<category><![CDATA[tragedy]]></category>

		<guid isPermaLink="false">http://tapanray.in/index.php/?p=448</guid>
		<description><![CDATA[Globally the pharmaceutical industry is going through a metamorphosis. The types of changes that are taking place today globally, perhaps has no precedence.. The key drivers of these changes are mainly the following: 1. A large number of patent expiration &#8230; <a href="http://www.tapanray.in/to-avoid-heparin-like-tragedy-in-future-a-robust-supply-chain-integrity-and-security-system-is-of-critical-importance/">Continue reading <span class="meta-nav">&#8594;</span></a>]]></description>
		<wfw:commentRss>http://www.tapanray.in/to-avoid-heparin-like-tragedy-in-future-a-robust-supply-chain-integrity-and-security-system-is-of-critical-importance/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>
